2024
Development and initial testing of mindful journey: a digital mindfulness-based intervention for promoting recovery from Substance use disorder
Roos C, Kiluk B, Carroll K, Bricker J, Mun C, Sala M, Kirouac M, Stein E, John M, Palmer R, DeBenedictis A, Frisbie J, Haeny A, Barry D, Fucito L, Bowen S, Witkiewitz K, Kober H. Development and initial testing of mindful journey: a digital mindfulness-based intervention for promoting recovery from Substance use disorder. Annals Of Medicine 2024, 56: 2315228. PMID: 38382111, PMCID: PMC10883107, DOI: 10.1080/07853890.2024.2315228.Peer-Reviewed Original ResearchConceptsSubstance use disordersMindfulness-based interventionsPhone coachingQualitative feedbackPromote recoveryEvidence of feasibilityUse disorderPhase 2Promote long-term recoveryApp featuresUnmet needsAdjunctive interventionTen adultsSmartphone appLong-term recoveryInterventionTherapy videosMindfulness practiceParticipantsOutpatient treatmentMind toolPhase 1CoachingAcceptance dimensionQuantitative ratings
2023
Tobacco use and cancer‐related symptom burden: Analysis of the US Population Assessment of Tobacco and Health Study
Price S, Palmer A, Fucito L, Graboyes E, Baker N, Rojewski A, Toll B. Tobacco use and cancer‐related symptom burden: Analysis of the US Population Assessment of Tobacco and Health Study. Cancer 2023, 129: 2385-2394. PMID: 37211959, PMCID: PMC10593116, DOI: 10.1002/cncr.34746.Peer-Reviewed Original ResearchConceptsSymptom burdenCurrent smokingCigarette smokingQuit attemptsTobacco useGreater fatiguePast-year quit attemptsCancer symptom burdenUS Population AssessmentCurrent cigarette smokingGreater symptom burdenTobacco treatment interventionsAdult cancer survivorsQuality of lifeSmoking quit attemptEmotional problemsRace/ethnicityCancer survivorsTobacco cessationHealth StudySmokingTreatment interventionsUS FoodMultivariate analysisSurvivors' interestPersonalized Digital Health Information to Substantiate Human-Delivered Exercise Support for Adults With Type 1 Diabetes
Ash G, Nally L, Stults-Kolehmainen M, De Los Santos M, Jeon S, Brandt C, Gulanski B, Spanakis E, Baker J, Weinzimer S, Fucito L. Personalized Digital Health Information to Substantiate Human-Delivered Exercise Support for Adults With Type 1 Diabetes. Clinical Journal Of Sport Medicine 2023, 33: 512-520. PMID: 36715983, PMCID: PMC10898917, DOI: 10.1097/jsm.0000000000001078.Peer-Reviewed Original ResearchConceptsContinuous glucose monitoringExercise supportHealth informationDigital health informationBody mass indexType 1 diabetesCommunity-based sampleSevere hypoglycemiaMass indexPsychosocial assessmentCGM useHigh satisfaction ratingsPhysician oversightType 1Future interventionsGlucose monitoringMedical readinessMolecular biomarkersBaseline observationsInterventionSatisfaction ratingsAdultsExerciseBehavioral skillsSingle group
2022
A Combined Laboratory and Field Test of a Smartphone Breath Alcohol Device and Blood Alcohol Concentration Estimator to Facilitate Moderate Drinking Among Young Adults
Leeman RF, Berey BL, Frohe T, Rowland BHP, Martens MP, Fucito LM, Stellefson M, Nixon SJ, O’Malley S. A Combined Laboratory and Field Test of a Smartphone Breath Alcohol Device and Blood Alcohol Concentration Estimator to Facilitate Moderate Drinking Among Young Adults. Psychology Of Addictive Behaviors 2022, 36: 710-723. PMID: 34766785, PMCID: PMC9381324, DOI: 10.1037/adb0000780.Peer-Reviewed Original ResearchUrgent Need for Novel Investigations of Treatments to Quit E-cigarettes: Findings from a Systematic Review
Palmer AM, Price SN, Foster MG, Sanford BT, Fucito LM, Toll BA. Urgent Need for Novel Investigations of Treatments to Quit E-cigarettes: Findings from a Systematic Review. Cancer Prevention Research 2022, 15: 569-580. PMID: 35816038, PMCID: PMC9444997, DOI: 10.1158/1940-6207.capr-22-0172.Peer-Reviewed Original ResearchConceptsE-cigarette cessationE-cigarettesSystematic reviewE-cigarette useSymptoms of dependenceCohort studyCigarette smokingPsychologic factorsQuit attemptsHealth concernCessationCold turkeySmokingLack of satisfactionHigher intentFuture studiesAdultsInterventionAdult samplesUrgent needLack of informationReviewSymptomsAbstinenceIndividualsCigarette Smoking in Response to COVID-19: Examining Co-Morbid Medical Conditions and Risk Perceptions
Fucito LM, Bold KW, Cannon S, Serrantino A, Marrero R, O’Malley S. Cigarette Smoking in Response to COVID-19: Examining Co-Morbid Medical Conditions and Risk Perceptions. International Journal Of Environmental Research And Public Health 2022, 19: 8239. PMID: 35886090, PMCID: PMC9317071, DOI: 10.3390/ijerph19148239.Peer-Reviewed Original ResearchConceptsChronic medical conditionsMedical conditionsCigarette smokingCOVID-19 risk perceptionCOVID-19 riskGreater oddsSmoking changesHigher COVID-19 risk perceptionsCo-morbid medical conditionsCOVID-19Tobacco cessation treatmentCoronavirus disease 2019 (COVID-19) pandemicDisease 2019 pandemicPublic health threatCessation treatmentMedical historyWhite raceSmokingSmoking behaviorSample of adultsOngoing COVID-19Younger ageLogistical regressionHealth threatPreventive healthcareSensitivity, specificity, and tolerability of the BACTrack Skyn compared to other alcohol monitoring approaches among young adults in a field‐based setting
Ash GI, Gueorguieva R, Barnett NP, Wang W, Robledo DS, DeMartini KS, Pittman B, Redeker NS, O’Malley S, Fucito LM. Sensitivity, specificity, and tolerability of the BACTrack Skyn compared to other alcohol monitoring approaches among young adults in a field‐based setting. Alcohol Clinical And Experimental Research 2022, 46: 783-796. PMID: 35567595, PMCID: PMC9179100, DOI: 10.1111/acer.14804.Peer-Reviewed Original ResearchExamining Tobacco Treatment Perceptions and Barriers Among Black vs. Non-Black Adults Attending Lung Cancer Screening
Bold KW, Cannon S, Ford BB, Neveu S, Sather P, Toll BA, Fucito LM. Examining Tobacco Treatment Perceptions and Barriers Among Black vs. Non-Black Adults Attending Lung Cancer Screening. Cancer Prevention Research 2022, 15: 327-333. PMID: 35063942, PMCID: PMC9064926, DOI: 10.1158/1940-6207.capr-21-0398.Peer-Reviewed Original ResearchConceptsLung cancer screeningCancer screeningTobacco treatmentWithdrawal symptomsRace/ethnicityTreatment perceptionsUS Preventive Services Task ForceHealth disparitiesAnnual lung cancerSmilow Cancer HospitalYale-New HavenCharacteristics of patientsHigh-risk patientsHigh-risk populationNon-Hispanic blacksTobacco-related health disparitiesAddress health disparitiesPatient characteristicsSmoking historyBlack patientsCancer HospitalLung cancerHigh riskPatientsSmokingHarm reduction for smokers with little to no quit interest: can tobacco policies encourage switching to e-cigarettes?
Buckell J, Fucito LM, Krishnan-Sarin S, O'Malley S, Sindelar JL. Harm reduction for smokers with little to no quit interest: can tobacco policies encourage switching to e-cigarettes? Tobacco Control 2022, 32: e173-e179. PMID: 35046127, PMCID: PMC9347898, DOI: 10.1136/tobaccocontrol-2021-057024.Peer-Reviewed Original ResearchConceptsGroup choicePolicy-relevant attributesDiscrete choice experimentPreference heterogeneityChoice experimentLatent classesCigarettes/e-cigarettesPolicy concernsLatent variable modelPolicyMenthol cigarette banVariable modelE-cigarettesOwn cigarettesQuit interestStrong preferenceCigarette banChoiceLittle interestLow interestHarm reductionTaxesSevere health consequencesAdult smokersLess harm
2021
The effect of varenicline on smoking and drinking outcomes among Black and White adults with alcohol use disorder and co-occurring cigarette smoking: A secondary analysis of two clinical trials
Haeny AM, Gueorguieva R, Montgomery L, Bold KW, Fucito LM, Wu R, Muvvala SB, Zweben A, O'Malley SS. The effect of varenicline on smoking and drinking outcomes among Black and White adults with alcohol use disorder and co-occurring cigarette smoking: A secondary analysis of two clinical trials. Addictive Behaviors 2021, 122: 106970. PMID: 34216871, PMCID: PMC9426655, DOI: 10.1016/j.addbeh.2021.106970.Peer-Reviewed Original ResearchConceptsEffects of vareniclineAlcohol use disorderCigarette smokingClinical trialsUse disordersWhite adultsEfficacy of vareniclineNumber of drinksVareniclineSmokingPrimary analysisAlcohol treatmentSecondary analysisAlcohol useTrialsBlack participantsDrinking outcomesLinear mixed modelsAdultsWhite peopleWhite participantsMixed modelingCigarettesDisordersTreatmentReward drinking and naltrexone treatment response among young adult heavy drinkers
Roos CR, Bold KW, Witkiewitz K, Leeman RF, DeMartini KS, Fucito LM, Corbin WR, Mann K, Kranzler HR, O'Malley SS. Reward drinking and naltrexone treatment response among young adult heavy drinkers. Addiction 2021, 116: 2360-2371. PMID: 33620746, PMCID: PMC8328878, DOI: 10.1111/add.15453.Peer-Reviewed Original Research
2020
Using Web-Based Social Media to Recruit Heavy-Drinking Young Adults for Sleep Intervention: Prospective Observational Study
Ash GI, Robledo DS, Ishii M, Pittman B, DeMartini KS, O'Malley SS, Redeker NS, Fucito LM. Using Web-Based Social Media to Recruit Heavy-Drinking Young Adults for Sleep Intervention: Prospective Observational Study. Journal Of Medical Internet Research 2020, 22: e17449. PMID: 32780027, PMCID: PMC7448185, DOI: 10.2196/17449.Peer-Reviewed Original ResearchConceptsAlcohol use disorderSleep interventionsSleep concernsYoung adultsAlcohol useWeb-based surveyBrief web-based surveyProspective observational studyHeavy-drinking young adultsYears of ageHigh response rateAlcohol prevention strategiesHeavy alcohol useAlcohol prevention programsHeavy drinking young adultsScreening eligibilityRisk factorsStudy enrolleesObservational studySleep programSleep problemsAlcohol screenerUse disordersPrevention strategiesResponse rate
2019
Evaluating the effect of switching to non-menthol cigarettes among current menthol smokers: an empirical study of a potential ban of characterising menthol flavour in cigarettes
Bold KW, Jatlow P, Fucito LM, Eid T, Krishnan-Sarin S, O'Malley S. Evaluating the effect of switching to non-menthol cigarettes among current menthol smokers: an empirical study of a potential ban of characterising menthol flavour in cigarettes. Tobacco Control 2019, 29: 624-630. PMID: 31685586, PMCID: PMC7259442, DOI: 10.1136/tobaccocontrol-2019-055154.Peer-Reviewed Original ResearchLongitudinal Findings from a Randomized Clinical Trial of Varenicline for Alcohol Use Disorder with Comorbid Cigarette Smoking
Bold KW, Zweben A, Fucito LM, Piepmeier ME, Muvvala S, Wu R, Gueorguieva R, O'Malley SS. Longitudinal Findings from a Randomized Clinical Trial of Varenicline for Alcohol Use Disorder with Comorbid Cigarette Smoking. Alcohol Clinical And Experimental Research 2019, 43: 937-944. PMID: 30817018, PMCID: PMC7039307, DOI: 10.1111/acer.13994.Peer-Reviewed Original ResearchConceptsEnd of treatmentAlcohol use disorderHeavy drinking daysMedical managementCigarette smokingComorbid cigarette smokingUse disordersDrinking daysCo-occurring alcohol use disorderHigh ratePlacebo-controlled trialBetter clinical outcomesAssessment of alcoholPercent of participantsVarenicline treatmentClinical outcomesSmoking abstinenceParallel groupClinical trialsTimeline FollowVareniclineSmoking behaviorAlcohol treatmentPosttreatment outcomesMultisite trialElectronic cigarette and tobacco use in individuals entering methadone or buprenorphine treatment
Baldassarri SR, Fiellin DA, Savage ME, Madden LM, Beitel M, Dhingra LK, Fucito L, Camenga D, Bollampally P, Barry DT. Electronic cigarette and tobacco use in individuals entering methadone or buprenorphine treatment. Drug And Alcohol Dependence 2019, 197: 37-41. PMID: 30769264, PMCID: PMC6637405, DOI: 10.1016/j.drugalcdep.2018.12.012.Peer-Reviewed Original ResearchConceptsOpioid use disorderOpioid agonist therapyCurrent cigarette smokingCigarette smokingEC useHigher oddsFormer smokersLower oddsPsychiatric distressPast cigarette smokingElectronic cigarette useAgonist therapyCurrent smokersBuprenorphine treatmentChronic painTobacco useNicotine dependenceUse disordersSmokingCigarette useMultivariate analysisElectronic cigarettesSmokersCigarettesMultivariate model
2018
Drinking Goals and Attainment in a Naltrexone Trial of Young Adult Heavy Drinkers
DeMartini KS, Foster DW, Corbin WR, Fucito LM, Romano D, Leeman RF, Kranzler HR, O’Malley S. Drinking Goals and Attainment in a Naltrexone Trial of Young Adult Heavy Drinkers. Journal Of Consulting And Clinical Psychology 2018, 86: 765-774. PMID: 30138015, PMCID: PMC6435339, DOI: 10.1037/ccp0000323.Peer-Reviewed Original ResearchConceptsTreatment outcomesAdult heavy drinkersYoung adult heavy drinkersHeavy drinkersDrinking goalEnd of treatmentPeak drinkingBetter treatment outcomesAlcohol use disorderImpact treatment outcomesTypical drinkingYoung adult drinkersEfficacy trialsUse disordersBrief counselingGoal settingIntervention effectsGoal-setting exercisesAdult drinkersDrinkersOutcomesDrinkingTreatmentImportant targetMidtreatmentA Pilot Clinical Trial of Smoking Cessation Services Implemented in the Workplace for Service Industry Employees
Bold KW, Kimmel L, Hanrahan TH, Romano D, Rojewski AM, Krishnan-Sarin S, Fucito LM, O’Malley S. A Pilot Clinical Trial of Smoking Cessation Services Implemented in the Workplace for Service Industry Employees. American Journal Of Health Promotion 2018, 33: 516-524. PMID: 30153737, PMCID: PMC7259449, DOI: 10.1177/0890117118795987.Peer-Reviewed Original ResearchConceptsSmoking cessation servicesService industry employeesCessation servicesQuit attemptsIndustry employeesEvidence-based tobacco treatmentPilot clinical trialEnd of treatmentFree pharmacotherapyTobacco treatmentPreliminary efficacyHelpful overallClinical trialsSmoking treatmentSuccessful abstinenceContingency managementEmployeesIndividual counselingTreatmentStatus SurveyPrimary measureService settingsHigh rateWorkplaceAbstinenceEffect of Varenicline Combined With Medical Management on Alcohol Use Disorder With Comorbid Cigarette Smoking: A Randomized Clinical Trial
O’Malley S, Zweben A, Fucito LM, Wu R, Piepmeier ME, Ockert DM, Bold KW, Petrakis I, Muvvala S, Jatlow P, Gueorguieva R. Effect of Varenicline Combined With Medical Management on Alcohol Use Disorder With Comorbid Cigarette Smoking: A Randomized Clinical Trial. JAMA Psychiatry 2018, 75: 129-138. PMID: 29261824, PMCID: PMC5838706, DOI: 10.1001/jamapsychiatry.2017.3544.Peer-Reviewed Original ResearchConceptsAlcohol use disorderMedical managementUse disordersCigarette smokingWeek 9Varenicline tartrateEfficacy of vareniclinePlacebo-controlled trialBehavioral health risksComorbid cigarette smokingRace/ethnicityAlcohol dependence criteriaSmoking 2Medication adherenceOutpatient clinicPlacebo pillsMean ageEligible participantsSmoking abstinenceClinical trialsParallel groupPlaceboMAIN OUTCOMEVareniclineWeek 13Reciprocal Variations in Sleep and Drinking Over Time Among Heavy-Drinking Young Adults
Fucito LM, Bold KW, Van Reen E, Redeker NS, O’Malley S, Hanrahan TH, DeMartini KS. Reciprocal Variations in Sleep and Drinking Over Time Among Heavy-Drinking Young Adults. Journal Of Psychopathology And Clinical Science 2018, 127: 92-103. PMID: 29172601, PMCID: PMC5785424, DOI: 10.1037/abn0000312.Peer-Reviewed Original Research
2017
Electronic cigarettes for adults with tobacco dependence enrolled in a tobacco treatment program: A pilot study
Baldassarri SR, Bernstein SL, Chupp GL, Slade MD, Fucito LM, Toll BA. Electronic cigarettes for adults with tobacco dependence enrolled in a tobacco treatment program: A pilot study. Addictive Behaviors 2017, 80: 1-5. PMID: 29304395, PMCID: PMC6463885, DOI: 10.1016/j.addbeh.2017.11.033.Peer-Reviewed Original ResearchConceptsTobacco treatment programTreatment-seeking smokersElectronic cigarettesWeek 24Tobacco treatmentTobacco smokersTreatment programTobacco treatment interventionsTobacco smokingPatch therapyTobacco dependenceEffective adjunctBehavioral counselingMean reductionSmokersSmoking outcomesTreatment settingsTreatment interventionsSmokingNicotine solutionPilot studyNicotineCigarettesSignificant differencesSubjects